• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Gene therapy for progressive renal diseases

Research Project

Project/Area Number 10470217
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionOsaka University

Principal Investigator

IMAI Enyu  Osaka University Graduate School of Medicine, Lecturer, 医学系研究科, 講師 (00223305)

Co-Investigator(Kenkyū-buntansha) ISAKA Yoshitaka  Osaka University Graduate School of Medicine, Medical Staff, 医学部・附属病院, 医員
KANEDA Yasuhumi  Osaka University Graduate School of Medicine, Professer, 医学系研究科, 教授 (10177537)
MORIYAMA Toshiki  Osaka University Graduate School of Medicine, Lecturer, 健康体育部, 講師 (30283815)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥13,200,000 (Direct Cost: ¥13,200,000)
Fiscal Year 2000: ¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 1999: ¥2,400,000 (Direct Cost: ¥2,400,000)
Fiscal Year 1998: ¥8,200,000 (Direct Cost: ¥8,200,000)
KeywordsTGF-β / antisense / gene therapy / HVJ-liposome / interstitial fibrosis / HVJリポソーム法 / 糖尿病性腎症 / 糸球体肥大 / 糸球体基底膜肥厚 / 進行性腎障害
Research Abstract

There is little doubt that molecular biological intervention therapy has come of age and tremendous excitements have emerged from its potential. A gene transfer technique, HVJ-liposome method is now applicable to the analysis of molecular aspects in pathophysiology of renal diseases, and further to a tool for gene therapy. We demonstrated that continuous delivery of chimeric soluble TGF-β receptor from the gene transferred skeletal muscle also inhibits the extracellular matrix expansion in experimental glomerulonephritis. Furthermore, we challenged whether in vivo gene transfer of antisense ODNs for TGF-β into interstitial fibroblasts can suppress the progression of interstitial fibrosis in unilateral ureteral obstruction model rats. Introduction of TGF-β1 antisense ODNs significantly reduced levels of TGF-β1 and types I collagen mRNA expression in obstructed kidneys, and consequently prevented the extent of interstitial fibrosis following ureteral obstruction. Taken together with clinical observation that up-regulation of TGF-β plays an important role in the formation of various kidney fibrosis, the manipulation of the overexpression of TGF-β may provide a novel way of therapeutic intervention to ameliorate the progression of the renal diseases.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (28 results)

All Other

All Publications (28 results)

  • [Publications] Isaka Y, et al: "Electroporation-Medeated PDGF Receptor-IgG Chimera Gene Trasfer Ameliorated Experimental Glomerulonephritis."Kidney Int.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Isaka Y, et al: "Prolonged Transgene Expression in Glomeruli Using and Epstein-Barr Virus Replicon Vector System Combined with AVE Type HVJ Liposomes."Kidney Int.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Isaka,Y, et al: "Transforming growth factor-β1 antisense oligodeoxynucleotides block intersutitial fibrosis in unilaterall ureteral obstruction."Kidney Int.. 58. 1885-1892 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Isaka,Y, et al: "Gene transfer targeting interstitial. Fibroblasts by the artificial viral envelope type hemagglutinating virus of Japan liposome method."Kidney Int.. 57. 1973-1980 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Isaka,Y, et al: "Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis"Kidney Int.. 55. 465-475 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imai,E.,Isaka,Y.: "Strategies of gene transfer to the kidney"Kidney Int.. 53. 264-272 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nakamura H, Isaka Y, Tsujie M, Akagi Y, Sudo T, Ohno N, Imai E, Hori M: "Electroporation-Mediated PDGF Receptor-IgG Chimera Gene Transfer Ameliorated Experimental Glomerulonephritis."Kidney Int. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsujie M, Isaka Y, Nakamura H, Kaneda Y, Imai E, Hori M: "Prolonged Transgene Expression in Glomeruli Using an Epstein-Barr Virus Replicon Vector System Combined with AVE Type HVJ Liposomes."Kidney Int. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Isaka Y, Tsujie M, Ando Y, Nakamura H, Kanada Y, Imai E, Horio M: "Transforming growth factor-β1 antisense oligodeoxynucleotides block intersutitial fibrosis in unilateral ureteral obstruction"Kidney Int. 58. 1885-1892 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsujie M, Isaka Y, Ando Y, Akagi Y, Kaneda Y, Ueda N, Imai E, Hori M.: "Gene transfer targeting interstitial fibroblasts by the artificial viral envelope type hemagglutinating virus of Japan liposome method."Kidney Int. 57. 1973-1980 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E: "Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis."Kidney Int. 55. 465-475 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imai E, Isaka Y: "Strategies of gene transfer to the kidney."Kidney Int. 53. 264-72 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nakamura H,Isaka Y,et al.: "Electroporation-Mediated PDGF Receptor-IgG Chimera Gene Transfer Ameliorated Experimental Glomerulonephritis"Kidney Int.. (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsujie M,Isaka Y,et al.: "Prolonged Transgene Expression in Glomeruli Using an Epstein-Barr Virus Replicon Vector System Combined with AVE Type HVJ Liposomes"kidney Int.. (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Isaka Y,et al: "Introduction of transforming growth factor-beta 1 antisense digodeosynucleotides into renal interstitial fibroblasts blodes interstitial fibrosis in unilate valureteral obstruction"kidney Int,. 58. 1885-1892 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsujie M,Isaka et,al: "Gene transfer targeting interstitial fibroblasts by the artificial viralenvelope type hemagglutinating virus of Japan liposome method."Kidney Int.. 57. 1973-1980 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Isaka Y,et al: "Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis"Kidney Int.. 55. 465-475 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Imai E,Isaka Y: "Strategies of gene transfer to the kidney"Kidney Int. 53. 264-272 (1998)

    • Related Report
      2000 Annual Research Report
  • [Publications] Enyu Imai, et al.: "Glowing Podocytes in Living Mouse : Transgenic Mouse Carrying a Podocyte Specific Promoter"Experimental Nephrology. 7・1. 63-66 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yoshitaka Isaka, et al.: "Cytokines and glomerulosclerosis"Nephrology Dialysis Transplantation. 14[Suppl 1]. 30-32 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yoshitaka Isaka: "Application of gene therapy to kidney diseases"Clinical Experimental Nephrology. 3. 147-153 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Enyu Imai, Yoshitaka Isaka: "New Paradigm of Gene Therapy : Skeletal-Muscle-Targeting Gene Therapy for Kidney Disease"Nephron. 83. 296-300 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Enyu Imai and Yoshitaka Isaka: "Strategies of gene transfer to the kidney" Kidney Int. 53. 264-272 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Isaka Y,et al: "The HVJ Liposome Method" Experimental Nephrology. 6. 144-147 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Imai E,et al: "Gene transfer and kidney disease" Journal of Nephrology. 11,2. 16-19 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Imai E,Akagi Y,Isaka Y: "Towards gene therapy for renal diseases" Nephrologie. 19. 397-402 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Isaka Y,et al: "Cytokines and glomerulostleroris" Nephrology Dialysis Transplanation. 14. 30-32 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Isaka Y,et al: "Gene therapy by transforming growth factor-β receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis" Kidney International. 55. 465-475 (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi